ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Six Grants Awarded, Five More On Way For Elderly Research

May 4, 1984

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

June 25, 2004

DeVita Reshuffling NCI Office Space

April 18, 1980

NCI director creates four new deputy director positions to manage the Institute.

February 20, 2004

DCT Advisors Approve Recompetition Of Drug Discovery Groups

June 23, 1995

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005